Related Experiment Video
Updated: Aug 14, 2026
09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Two-year remission in Nigerian epileptics
A Ogunniyi1, O S Oluwole, B O Osuntokun
1Department of Medicine, University College Hospital, Ibadan, Nigeria.
East African Medical Journal
|November 6, 1998
Summary
This study on Nigerian epilepsy patients found that regular clinic attendance and therapy compliance are crucial for seizure remission. Improving health education and early treatment can help prevent chronic epilepsy.
Area of Science:
- Neurology
- Public Health
Background:
- Epilepsy management in Nigeria faces challenges with patient adherence.
- Understanding seizure profiles and treatment outcomes is vital for improving care.
Purpose of the Study:
- To investigate the seizure profile of Nigerian epileptic patients.
- To identify factors associated with seizure remission in epilepsy patients.
- To highlight challenges in epilepsy management, including clinic default and therapy compliance.
Main Methods:
- A study involving 208 male and 137 female Nigerian epileptic patients.
- Analysis of seizure types, age at onset, and follow-up data for over two years.
- Statistical analysis to determine factors associated with seizure remission, including odds ratios (OR) and 95% confidence intervals (CI).
Main Results:
- Partial seizures predominated (53.3%), with a mean age at onset of 21 years.
- High clinic default rate (107/255) and low therapy compliance (25.5%) were observed.
- Drug compliance (OR = 4.4) and fewer than six pre-therapy attacks (OR = 2.3) were linked to two-year seizure remission.
Conclusions:
- High rates of clinic default and low therapy compliance are significant barriers to effective epilepsy management in Nigeria.
- Enhanced health education and prompt initiation of therapy are essential to reduce the incidence of chronic epilepsy.
More Related Videos
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
06:04Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
Published on: August 16, 2024
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.